Precision Oncology Today
An Epigenetic Exploration of Cancer
Looking beyond genes alone as the drivers of this collection of diseases promises to improve treatment and might one day lead to prevention.
How Artificial Intelligence Is Driving Changes in Radiology
The umbrella term artificial intelligence (AI) encompasses the subfields of machine learning. With the advent of AI came the emergence of radiomics, where digital images that are normally interpreted by radiologists in a qualitative way are transformed into quantitative data.
Trending on Inside Precision Medicine
New Draft Guidance from FDA Looks to Refine Accelerated Approval of Oncology Drugs
The FDA published draft guidance regarding the design of clinical trials that the agency hopes can support the accelerated approval (AA) applications for drugs entering oncology clinical trials.
Lung Cancer Growth Suppressed by Anticancer and Antifibrotic Drug Combo
Researchers at Academia Sinica, National Yang Ming Chiao Tung University, National Taiwan University Hospital, and National Taiwan University, have shown how blocking the activity of fibroblasts can help to treat lung cancer.
Time of Day May Be Important for Cancer Diagnosis and Treatment
Key biologic features of tumor progression are influenced by the circadian rhythm, which could be used to optimize timing of drug delivery and maximize safety and efficacy.